XML 98 R64.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Details)
 12 Months Ended
Dec. 31, 2024
USD ($)
director
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
shares
Unrecognized compensation cost and vesting period      
Unrecognized compensation costs related to unvested stock-based compensation arrangements | $ $ 24,200,000    
Weighted-average period for recognition of unrecognized stock-based compensation expense 2 years 2 months 12 days    
Other disclosures      
Shares issued and committed to issue | shares 22,029 14,700 16,700
Shares committed to be issued | shares 21,266 9,800 9,300
Shares expected to be settled In cash | shares 763 4,900 7,400
Stock-based compensation expense recognized in operating expenses | $ $ (13,112,000) $ (19,726,000) $ (12,503,000)
Tax benefit of stock-based compensation expense in provision for income taxes | $ 3,204,000 4,808,000 3,133,000
Share-based Payment Arrangement, Expense, after Tax | $ $ 9,908,000 $ 14,918,000 9,370,000
Weighted average grant date, period 60 days    
Restricted Stock Units      
Restricted stock unit activity      
Outstanding at the beginning of the period (in shares) | shares 378,000    
Awarded (in shares) | shares 161,000    
Vested (in shares) | shares (167,000)    
Forfeited (in shares) | shares (36,000)    
Outstanding at the end of the period (in shares) | shares 336,000 378,000  
Outstanding and expected to vest at the end of the period (in shares) | shares 327,000    
Weighted-Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) | $ / shares $ 102.87    
Awarded (in dollars per share) | $ / shares 177.60    
Vested (in dollars per share) | $ / shares 103.64    
Forfeited (in dollars per share) | $ / shares 116.62    
Outstanding at the end of the period (in dollars per share) | $ / shares 130.42 $ 102.87  
Outstanding and expected to vest at the end of the period (in dollars per share) | $ / shares    
Aggregate Intrinsic Value      
Outstanding at the end of the period (in dollars) | $ $ 55,333,000 $ 74,850,000  
Outstanding and expected to vest at end of the period (in dollars) | $ $ 54,249,000    
Closing price per share (in dollars per share) | $ / shares $ 165.83    
Total intrinsic value of awards vested (in dollars) | $ $ 31,800,000 $ 20,300,000 25,600,000
Weighted-Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) | $ / shares $ 102.87    
Forfeited (in dollars per share) | $ / shares 116.62    
Outstanding at the end of the period (in dollars per share) | $ / shares $ 130.42 $ 102.87  
Aggregate Intrinsic Value      
Outstanding at the end of the period (in dollars) | $ $ 55,333,000 $ 74,850,000  
Other disclosures      
Stock-based compensation expense recognized in operating expenses | $ $ (800,000)    
Phantom Share Units (PSUs)      
Other disclosures      
Vesting period 3 years    
2011 Plan | Non-Qualified Stock Options      
Stock-Based Compensation      
Maximum common stock shares that may be issued under plan | shares 16,300,000    
Stock Bonus Plan | Restricted Stock Units      
Aggregate Intrinsic Value      
Total intrinsic value of awards vested (in dollars) | $ $ 3,700,000 $ 1,900,000 $ 1,500,000
Independent directors | Restricted Stock Units      
Aggregate Intrinsic Value      
Number Of Directors | director 7    
Other disclosures      
Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense | $ $ 900,000    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares 4,692    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares $ 173.89    
Employees | Restricted Stock Units      
Restricted stock unit activity      
Awarded (in shares) | shares 156,000    
Weighted-Average Exercise Price      
Awarded (in dollars per share) | $ / shares $ 177.73    
Other disclosures      
Vesting period 4 years